Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pelubiprofen CR in Acute Traumatic Injury
NCT03874247Phase 3Unknown
- Sponsor
- Daewon Pharm
- Start
- Feb 2019
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pelubiprofen in Physical trauma, acute pain, sponsored by Daewon Pharm. Status: unknown.
02
Drugs
pelubiprofen
03
Conditions
Physical traumaacute pain
Beyond the preview
Go deeper on NCT03874247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03874247.